
Corporate
IN8bio's Glioblastoma Therapy Nearly Doubles Survival: CEO Details Path to FDA at Noble Capital Conference
7h ago
You're signed outSign in or to get full access.
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
Research analysts covering IN8BIO.